Winton Capital »

Eliem Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Eliem Therapeutics (CLYM) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Eliem Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Eliem Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eliem Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $140k 28k 5.09

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ge Vernova (GEV)
Select Sector Spdr Tr Sbi Int-utils (XLU)
Deckers Outdoor Corporation (DECK)
Fmc Corp Com New (FMC)
3M Company (MMM)
Crane Company Common Stock (CR)
International Paper Company (IP)
Amphenol Corp Cl A (APH)
W.R. Berkley Corporation (WRB)
Williams-Sonoma (WSM)
Kellogg Company (K)
Lattice Semiconductor (LSCC)
Broadcom (AVGO)
Tetra Tech (TTEK)

View all positions for Winton Capital

Top funds holding Eliem Therapeutics

RA Capital Management
Samsara BioCapital
Boxer Capital
BlackRock
Affinity Asset Advisors
T. Rowe Price Associates
Geode Capital Management
Driehaus Capital Management
Point72 Asset Management
Nan Fung Group Holdings
Northern Trust
Dr. Jeffrey R. Jay, M.D.
Monashee Investment Management
Ikarian Capital
TD Asset Management

View all funds holding Eliem Therapeutics